Roger Adams Laboratory, Department of Chemistry , University of Illinois , Urbana , Illinois 61801 , United States.
J Am Chem Soc. 2018 May 30;140(21):6668-6684. doi: 10.1021/jacs.8b03187. Epub 2018 May 15.
Silicon-containing compounds have been largely ignored in drug design and development, despite their potential to improve not only the potency but also the physicochemical and ADMET ( absorption, distribution, metabolism, excretion, toxicity) properties of drug-like candidates because of the unique characteristics of silicon. This deficiency is in large part attributable to a lack of general methods for synthesizing diverse organosilicon structures. Accordingly, a new building block strategy has been developed that diverges from traditional approaches to incorporation of silicon into drug candidates. Flexible, multi-gram-scale syntheses of silicon-containing tetrahydroquinoline and tetrahydroisoquinoline building blocks are described, along with methods by which diversely functionalized silicon-containing nitrogen heterocycles can be rapidly built using common reactions optimized to accommodate the properties of silicon. Furthermore, to better clarify the liabilities and advantages of silicon incorporation, select compounds and their carbon analogues were challenged in ADMET-focused biological studies.
尽管硅化合物具有提高药物候选物的效力以及改善其物理化学和 ADMET(吸收、分布、代谢、排泄、毒性)性质的潜力,但由于硅的独特性质,它们在药物设计和开发中基本上被忽视了。这种缺陷在很大程度上归因于缺乏合成各种有机硅结构的通用方法。因此,已经开发出一种与将硅纳入药物候选物的传统方法不同的新构建块策略。本文描述了含硅四氢喹啉和四氢异喹啉砌块的灵活、多克规模合成方法,以及使用经过优化以适应硅性质的常见反应快速构建各种官能化含硅氮杂环的方法。此外,为了更好地阐明硅掺入的缺点和优势,在以 ADMET 为重点的生物学研究中对选定的化合物及其碳类似物进行了挑战。